Skip to search formSkip to main contentSkip to account menu

Primacor

Known as: Sanofi Brand of Milrinone Lactate, Sanofi Synthelabo Brand of Milrinone Lactate, Sanofi Winthrop Brand of Milrinone Lactate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Acute neurological injuries cause catecholamine-induced cardiac damage and can result in or ex-acerbate preexisting cardiac… 
2013
2013
ABSTRACT In this study the aim was to determine the protective effect of milrinone on rats that have mesenteric ischemia. In… 
2009
2009
Background and purpose:  Previous studies have suggested a regulation of 5‐hydroxytryptamine (5‐HT) neurons by the… 
Review
2001
Review
2001
Osanetant is a neurokinin (NK3) receptor antagonist under development by Sanofi-Synthélabo (formerly Sanofi) as a potential… 
Highly Cited
2000
Highly Cited
2000
To investigate differences in agonist affinity, potency, and efficacy across rat brain regions, five representative cannabinoid… 
Highly Cited
2000
Highly Cited
2000
PURPOSE This phase II study tested the efficacy and safety of tirapazamine (Sanofi Synthelabo Research, Malvern, PA), a… 
1998
1998
Naming prescription and over-the-counter drugs is a painstaking process. Every drug receives three distinct names: the chemical… 
1997
1997
In order to promote applications of recycled automobile tires, composite materials of recycled rubber tire particles with…